Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126516912 | 12651691 | 2 | F | 201607 | 20160816 | 20160815 | 20160818 | EXP | DE-ACTELION-A-CH2016-140148 | ACTELION | 73.00 | YR | E | F | Y | 0.00000 | 20160818 | MD | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126516912 | 12651691 | 1 | PS | UPTRAVI | SELEXIPAG | 1 | Oral | 400 ?G, BID | 207947 | 400 | UG | TABLET | BID | ||||||
| 126516912 | 12651691 | 2 | SS | UPTRAVI | SELEXIPAG | 1 | Oral | 200 ?G, BID | 207947 | 200 | UG | TABLET | BID | ||||||
| 126516912 | 12651691 | 3 | SS | UPTRAVI | SELEXIPAG | 1 | Oral | 600 ?G, BID | 207947 | 600 | UG | TABLET | BID | ||||||
| 126516912 | 12651691 | 4 | SS | REVATIO | SILDENAFIL CITRATE | 1 | Oral | 10 MG, TID | U | U | 0 | 10 | MG | TID | |||||
| 126516912 | 12651691 | 5 | C | ACC | ACETYLCYSTEINE | 1 | Oral | 600 MG, QD | U | 0 | 600 | MG | QD | ||||||
| 126516912 | 12651691 | 6 | C | FUROSEMID | FUROSEMIDE | 1 | Oral | 125 MG, BID | U | 0 | 125 | MG | BID | ||||||
| 126516912 | 12651691 | 7 | C | BISOPROLOL | BISOPROLOL | 1 | Oral | 1.25 UNK, UNK | U | 0 | QD | ||||||||
| 126516912 | 12651691 | 8 | C | PANTOPRAZOL | PANTOPRAZOLE SODIUM | 1 | Oral | 40 M, BID | U | 0 | BID | ||||||||
| 126516912 | 12651691 | 9 | C | MARCOUMAR | PHENPROCOUMON | 1 | U | 0 | |||||||||||
| 126516912 | 12651691 | 10 | C | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | 18 ?G, OD | U | 0 | 18 | UG | QD | |||||||
| 126516912 | 12651691 | 11 | C | SPIROBETA | SPIRONOLACTONE | 1 | 50 MG, QD | U | 0 | 50 | MG | QD | |||||||
| 126516912 | 12651691 | 12 | C | SIMVASTATIN. | SIMVASTATIN | 1 | UNK, OD | U | 0 | 20 | MG | QD | |||||||
| 126516912 | 12651691 | 13 | C | KALINOR RETARD P | POTASSIUM CHLORIDE | 1 | UNK, OD | U | 0 | QD | |||||||||
| 126516912 | 12651691 | 14 | C | NOVAMINSULFON | METAMIZOLE | 1 | UNK, PRN | U | 0 | ||||||||||
| 126516912 | 12651691 | 15 | C | CARMEN | LERCANIDIPINE | 1 | U | 0 | |||||||||||
| 126516912 | 12651691 | 16 | C | BERODUAL | FENOTEROL HYDROBROMIDEIPRATROPIUM BROMIDE | 1 | UNK, TID | U | 0 | TID | |||||||||
| 126516912 | 12651691 | 17 | C | AQUAPHOR | PETROLATUM | 1 | 10 MG, QD | U | 0 | 10 | MG | QD | |||||||
| 126516912 | 12651691 | 18 | C | UNACID | AMPICILLIN SODIUMSULBACTAM SODIUM | 1 | UNK, BID | U | 0 | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126516912 | 12651691 | 1 | Pulmonary arterial hypertension |
| 126516912 | 12651691 | 4 | Pulmonary arterial hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126516912 | 12651691 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126516912 | 12651691 | Diarrhoea | |
| 126516912 | 12651691 | Nausea | |
| 126516912 | 12651691 | Oral pain | |
| 126516912 | 12651691 | Pain | |
| 126516912 | 12651691 | Pain in jaw | |
| 126516912 | 12651691 | Respiratory failure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126516912 | 12651691 | 1 | 20160717 | 20160727 | 0 | |
| 126516912 | 12651691 | 2 | 20160703 | 20160716 | 0 | |
| 126516912 | 12651691 | 3 | 20160728 | 20160801 | 0 | |
| 126516912 | 12651691 | 4 | 201310 | 0 |